Capstone Investment Advisors’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Capstone Investment Advisors’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-83,060	Closed	-$2.11M	–	1476
2019 Q1	$2.11M	Buy	+83,060	New	+$1.47M	0.02%	587

Capstone Investment Advisors's NITE Position: Q2 2019 in Review

Capstone Investment Advisors sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 83,060 shares — an estimated $2.11M sold.

Capstone Investment Advisors first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $2.11M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Capstone Investment Advisors reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Capstone Investment Advisors sold 83,060 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $2.11M.
Capstone Investment Advisors first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Capstone Investment Advisors's Nightstar Therapeutics plc American Depositary Shares position peaked at $2.11M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Capstone Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.